Cefoperazone for empiric therapy in patients with impaired renal function
- 1 August 1986
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 81 (2) , 229-236
- https://doi.org/10.1016/0002-9343(86)90256-1
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Changing Patterns of Resistance to New Beta-Lactarn AntibioticsThe American Journal of Medicine, 1984
- Pharmacokinetics of Cefoperazone in Patients with Normal and Impaired Hepatic and Renal FunctionClinical Infectious Diseases, 1983
- Ceftizoxime: collaborative multiphased in-vitro evaluation including tentative interpretive standards for disc susceptibility tests, -lactamase stability, and inhibitionJournal of Antimicrobial Chemotherapy, 1982
- Moxalactam therapy of infections caused by cephalothin-resistant bacteria: influence of serum inhibitory activity on clinical response and acquisition of antibiotic resistance during therapyAntimicrobial Agents and Chemotherapy, 1981
- Determination of cephalosporins in biological material by reversed-phase liquid column chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1981
- Pharmacokinetics of cefoperazone in normal volunteers and subjects with renal insufficiencyAntimicrobial Agents and Chemotherapy, 1981
- Cefotaxime: in vitro activity and tentative interpretive standards for disk susceptibility testingAntimicrobial Agents and Chemotherapy, 1980
- Cefoperazone (T-1551), a new semisynthetic cephalosporin: comparison with cephalothin and gentamicinAntimicrobial Agents and Chemotherapy, 1980
- Comparative Activities of the Oxa-β-Lactam LY127935, Cefotaxime, Cefoperazone, Cefamandole, and Ticarcillin Against Multiply Resistant Gram-Negative BacilliAntimicrobial Agents and Chemotherapy, 1980
- Gram-Negative BacteremiaArchives of internal medicine (1960), 1962